Frontier Capital Management CO LLC Viking Therapeutics, Inc. Transaction History
Frontier Capital Management CO LLC
- $9.58 Billion
- Q2 2024
A detailed history of Frontier Capital Management CO LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Frontier Capital Management CO LLC holds 450,197 shares of VKTX stock, worth $28.1 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
450,197
Previous 165,409
172.17%
Holding current value
$28.1 Million
Previous $13.6 Million
75.95%
% of portfolio
0.25%
Previous 0.13%
Shares
2 transactions
Others Institutions Holding VKTX
# of Institutions
442Shares Held
63.3MCall Options Held
6.23MPut Options Held
2.97M-
Vanguard Group Inc Valley Forge, PA10.1MShares$629 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$376 Million0.01% of portfolio
-
State Street Corp Boston, MA5.12MShares$319 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.25MShares$140 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.86MShares$116 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $4.78B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...